Massachusetts H2432 aims to reduce pancreatic cancer incidence and death through prevention, screening, and education programs.
Massachusetts H2432 seeks to reduce pancreatic cancer incidence and death by implementing a comprehensive initiative. This includes coordinated prevention, screening, education, and support programs. The bill mandates the development of a standard consent form for tissue donation and banking for research. It also establishes a pancreatic cancer advisory council to investigate clinical trial availability and make recommendations. The Department of Public Health will conduct a study on pancreatic cancer prevalence and unmet needs, presenting findings by June 30, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.